Molecular Profiling of Mouse Models of Loss or Gain of Function of the KCNT1 (Slack) Potassium Channel and Antisense Oligonucleotide Treatment
The potassium sodium-activated channel subtype T member 1 (<i>KCNT1</i>) gene encodes the Slack channel K<sub>Na</sub>1.1, which is expressed in neurons throughout the brain. Gain-of-function variants in <i>KCNT1</i> are associated with a spectrum of epilepsy synd...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/14/11/1397 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The potassium sodium-activated channel subtype T member 1 (<i>KCNT1</i>) gene encodes the Slack channel K<sub>Na</sub>1.1, which is expressed in neurons throughout the brain. Gain-of-function variants in <i>KCNT1</i> are associated with a spectrum of epilepsy syndromes, and mice carrying those variants exhibit a robust phenotype similar to that observed in patients. <i>Kcnt1</i> knockout (KO) mice, however, have a normal lifespan without any epileptic phenotype. To understand the molecular differences between these two models, we conducted a comprehensive proteomic analysis of the cerebral cortices of <i>Kcnt1</i> KO and <i>Kcnt1</i><sup>R455H/+</sup> mice, an animal model bearing a cytoplasmic C-terminal mutation homologous to a human R474H variant that results in EIMFS. The greatest change observed in <i>Kcnt1</i> KO mice compared to the wild-type mice was the increased expression of multiple proteins of the inner mitochondrial membrane. Electron microscopy studies of cortical mitochondria from <i>Kcnt1</i> KO mice further confirmed a significant increase in the density of mitochondrial cristae compared to that in wild-type mice. <i>Kcnt1</i> reduction by a murine-specific <i>Kcnt1</i> antisense oligonucleotide (ASO) in <i>Kcnt1</i><sup>R455H/+</sup> mice partially corrected the proteomic dysregulations in the disease model. The results support the hypothesis that ASO-mediated <i>KCNT1</i> reduction could be therapeutically useful in the treatment of <i>KCNT1</i> epilepsies. |
|---|---|
| ISSN: | 2218-273X |